Correction to Synthetic Approaches to the New Drugs Approved

This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

Addition/Correction Cite This: J. Med. Chem. 2017, 60, 8680-8680

pubs.acs.org/jmc

Correction to Synthetic Approaches to the New Drugs Approved During 2015 Andrew C. Flick, Hong X. Ding, Carolyn A. Leverett, Robert E. Kyne, Jr., Kevin K.-C. Liu, Sarah J. Fink, and Christopher J. O’Donnell* Journal of Medicinal Chemistry 2017, 60, 6480−6515. DOI: 10.1021/acs.jmedchem.7b00010 Page 6501. The structures of compounds 176, 177, 178, and XXII in Scheme 33 are drawn incorrectly. In all four of these structures the furanyl oxygen and gem-dimethyl group need to be transposed. The corrected Scheme 33 is below. Scheme 33. Synthesis of Polmacoxib (XXII)

Published: October 16, 2017 © 2017 American Chemical Society

8680

DOI: 10.1021/acs.jmedchem.7b01452 J. Med. Chem. 2017, 60, 8680−8680